Verucerfont
CAS: 885220-61-1
Ref. 3D-KKB22061
| 1mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
Name:
Verucerfont
Synonyms:
- Pyrazolo[1,5-a]pyrimidin-7-amine, 3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]-
- NBI 77860
- 3-(4-Methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]pyrazolo[1,5-a]pyrimidin-7-amine
- GSK 561679A
Description:
Verucerfont is a drug that binds to the glucocorticoid receptor and inhibits transcription. It has been shown to have potent anti-inflammatory effects in mouse models of inflammatory diseases, such as arthritis and colitis, by inhibiting cytokine production. Verucerfont also potently inhibits the synthesis of proinflammatory cytokines in human cells, including IL-1β, IL-6, and TNFα. Verucerfont has not been shown to be effective for treating inflammatory diseases in women.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
406.48 g/mol
Formula:
C22H26N6O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
